Pathogenesis Often xenobiotic-induced and may be associated with other forms of liver damage
Clinical studies have consistently shown that consistent intake of glutathione tablets for hyperpigmentation can lead to visible improvements in skin brightness, even tone, and reduction of dark spots within 812 weeks
Growth hormone therapy and its relationship to insulin resistance
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request
If you have commercial GLP-1 coverage, you are welcome to join our monthly GLP-1 program to obtain concierge weight loss coverage with frequent check-ins, close monitoring, and body composition scans to monitor progress

Reported benefits (per available research): Studied for restoring more youthful pulsatile GH and IGF-1 secretion in older adults, based on a small 1997 randomized, placebo-controlled human trial of a closely related GHRH(1-29) analog published in the Journal of Clinical Endocrinology & Metabolism May support gains in lean body mass in men specifically: that same 16-week trial found a statistically significant increase in lean body mass in men but not in women, alongside a significant increase in skin thickness (a marker of dermal collagen) in both sexes Proposed to support broader recovery and body-composition goals tied to growth-hormone-axis activity, though sermorelin-specific modern adult trial data remains thin, and much of the anti-aging and muscle-building framing used in commercial marketing outpaces the current clinical evidence base Known risks and side effects: Injection-site reactions (pain, swelling, or redness) are the most commonly reported adverse event associated with sermorelin therapy in manufacturer drug-labeling data Headache, flushing, dizziness, difficulty swallowing, hyperactivity, drowsiness, and hives have also been reported less commonly per that same labeling data
